Diffuse alveolar hemorrhage associated with ustekinumab treatment
- 4 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 78 (14) , 1277-1281
Abstract
Purpose: A case of diffuse alveolar hemorrhage (DAH) occurring as a reaction to ustekinumab therapy is reported. Summary: After starting ustekinumab for treatment of psoriatric arthritis, a 46-year-old female presented with flu-like symptoms and cough with blood-tinged sputum that had begun 1 week previously. Her initial computed tomography scan of the chest demonstrated bilateral ground-glass opacities. On bronchoscopy, the bronchoalveolar lavage (BAL) return became bloodier from sample 1 to samples 2 and 3. Her BAL fluid was more than 90% hemosiderin-laden macrophages, a finding consistent with DAH. We ruled out infectious etiologies and other common vasculitis conditions that can cause DAH. A diagnosis of ustekinumab-induced DAH was made due to a temporal relationship between initiation of the drug and the patient’s presentation and the absence of infection and other alternate diagnosis. Prior case reports including ustekinumab-induced pneumonitis, interstitial lung disease with a granulomatous component, and lupus syndrome have been reported, with this being the first case of DAH in a patient undergoing treatment of psoriatic arthritis. Conclusion: A 46-year-old woman developed DAH during ustekinumab treatment. Symptoms abated after drug discontinuation and supportive treament. Clinicians must remain mindful of this rare complication of ustekinumab use in order to avoid potential delays in appropriate DAH treatment.Keywords
This publication has 23 references indexed in Scilit:
- Ustekinumab‐induced drug eruption resembling lymphocytic infiltration (of Jessner–Kanof) and lupus erythematosus tumidusBritish Journal of Clinical Pharmacology, 2015
- Interstitial pneumonia in two patients with psoriasis during ustekinumab treatmentThe Journal of Dermatology, 2015
- Pneumopathie à éosinophiles chez un patient atteint de psoriasis en plaques traité par ustékinumabAnnales de Dermatologie et de Vénéréologie, 2015
- Diffuse Alveolar Haemorrhage: A Fatal Complication After Alemtuzumab Induction Therapy in Renal TransplantationTransplantation Proceedings, 2015
- Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxisEuropean Journal Of Dermatology, 2014
- Diffuse Alveolar Hemorrhage as a Fatal Adverse Effect of Bevacizumab: An Autopsy CaseJapanese Journal of Clinical Oncology, 2014
- A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trialBritish Journal of Dermatology, 2012
- Diffuse Alveolar Hemorrhage Following AlemtuzumabChest, 2008
- Diffuse alveolar hemorrhage following gemtuzumab ozogamicinBone Marrow Transplantation, 2005
- Diffuse Alveolar Hemorrhage After Infliximab Treatment of Crohnʼs DiseaseInflammatory Bowel Diseases, 2004